This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Enrico Luzzi: Innovator in Meningococcal Vaccine Development
Introduction
Enrico Luzzi is a notable inventor based in Siena, Italy. He has made significant contributions to the field of immunology, particularly in the development of meningococcal vaccines. His work focuses on enhancing the effectiveness of these vaccines through innovative methodologies.
Latest Patents
Enrico Luzzi holds a patent titled "Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines." This patent provides compositions, methods, and kits for assessing the immunogenicity and potency of meningococcal capsular saccharide vaccines. The assessment is based on measuring the binding of a bactericidal antibody to a capsular saccharide component in the vaccine. He has 1 patent to his name.
Career Highlights
Throughout his career, Enrico Luzzi has worked with prominent companies in the pharmaceutical industry. He has been associated with Novartis AG and GlaxoSmithKline Biologicals SA, where he contributed to various projects aimed at improving vaccine efficacy and safety.
Collaborations
Enrico has collaborated with several professionals in his field, including Cristiana Balocchi and Marilena Paludi. These collaborations have furthered his research and development efforts in vaccine technology.
Conclusion
Enrico Luzzi's innovative work in the field of meningococcal vaccines highlights his commitment to improving public health through scientific advancements. His contributions continue to influence the development of effective immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile